Selena Maranjian

This company is a very early-stage AI business. It could skyrocket over the coming years, but it might not.

Robotic surgery is a hot field, with new entrants coming.

Its valuation seems incredibly low. Is it a value trap?

These highfliers have flown high indeed, and still have much growth potential -- and reasonable prices.

These have been amazing growers -- and still have plenty of room to run.

The company has orders worth way more than its annual revenue.

Dividend-paying stocks are an excellent choice for investors in or near retirement.

If tens of billions of dollars of investments pay off, Meta Platforms can win big.

It's smart to not expect a lot from Social Security -- here's why.

This financial stock has soared some 169% over the past year.